Cyclic dinucleotides, which are a type of signaling substance for
cancer treatment, are secondary messengers of
intracellular events initiated by GPCR activation and act as a
stimulator of interferon genes (STING), and thus can have a significant effect on tumor suppression. Meanwhile, when
cancer occurs in a subject,
angiogenesis and
cell growth proceed at a very
high rate in the body, and thus an
oxygen-deficient environment is created due to incomplete
angiogenesis in
cancer tissues, which may be very suitable for the proliferation of
anaerobic bacteria such as
Salmonella sp. strains or E. coli. Therefore, the present invention relates to
a DNA construct into which is introduced a
gene for an
enzyme that synthesizes a signaling substance for
cancer treatment, e.g., a cyclic dinucleotide, or to a strain transformed with a vector comprising the
DNA construct. The
DNA construct or the strain transformed with a vector comprising the
DNA construct, according to the present invention, targets cancer in a subject and then secretes C-di-AMP or C-di-GMP synthase in the surrounding environment of the cancer, and thus can very effectively prevent or treat cancer and, at the same time, can diagnose cancer in real time.